This content is machine translated Journal Club Nephrolithiasis and gout: SGLT2i could be an effective supplement Nephrolithiasis and gout are diseases with an increasing global burden and often co-occur with type 2 diabetes mellitus. SGLT2 inhibitors, which were first approved for the treatment of hyperglycemia in…
View Post 5 min This content is machine translated SDNTT register data Psychological comorbidities in psoriasis Inflammatory systemic diseases such as psoriasis are associated with a high risk of comorbidity. In addition to cardiometabolic diseases, mental disorders are particularly common in this patient population. As part…
View Post 3 min This content is machine translated Antiphospholipid syndrome Preferably anticoagulate with VKA or heparin Antiphospholipid syndrome (APS) is an acquired thrombophilia and is associated with a high risk of venous, arterial or microvascular thrombosis. In APS with thrombotic manifestations, lifelong anticoagulation is generally indicated.…
View Post 3 min This content is machine translated Case report: Sjögren's syndrome Calcinosis cutis as a rare manifestation Calcinosis cutis is a challenging, disabling condition commonly seen in patients with systemic sclerosis or dermatomyositis. Calcinosis cutis in patients with Sjögren’s syndrome is very rare and only a few…
View Post 5 min This content is machine translated Journal Club GPP flares: new real-world data published Relapses characterized by large pustules on the skin are characteristic of generalized pustular psoriasis (GPP) and can be associated with systemic inflammatory reactions and serious complications. A study published this…
View Post 7 min This content is machine translated Sponsored Content: Rheumatoid arthritis Switching to upadacitinib as an advantageous alternative to TNFi cycling [1] The treatment of rheumatoid arthritis (RA) has made significant progress in recent years, but therapy remains a challenge for many patients: up to 60 % of those affected either do…
View Post 9 min This content is machine translated System therapy for psoriasis Expanded possibilities thanks to practical innovations Compared to the past, there are now more and more effective systemic therapies available. This has been helped by a surge in innovation that has produced a wide range of…
View Post 7 min This content is machine translated Psoriatic Arthritis Prediction and early intervention – current research initiatives Psoriasis often affects the joints during the course of the disease – around a third of those affected develop psoriatic arthritis (PsA) over time. Improving early detection and developing preventive…
View Post 3 min This content is machine translated Rheumatologic overlap syndrome When RA, SSc and SLE strike together Overlap syndromes, which include systemic scleroderma (SSc), rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), are rare. When the symptoms of the three autoimmune diseases occur simultaneously, this overlap poses…
View Post 7 min This content is machine translated Systemic disease psoriasis Keep an eye on comorbidities Comorbidities may already be present at the initial manifestation of plaque psoriasis, but sometimes these only develop later in the course of the disease. Taking this into account appropriately can…
View Post 4 min This content is machine translated Sponsored Content: Crohn's disease Biomarkers underline superiority of risankizumab compared to ustekinumab in Crohn’s disease [1] In the SEQUENCE study, risankizumab was compared with ustekinumab for the treatment of Crohn’s disease (CD) in patients who had failed anti-TNF therapies. Biomarkers such as fecal calprotectin (FC) and…
